BIM:EPA
BioMerieux SA
€86,85
arrow_downward
-0,46%(-0,40) 1D
19 Okt., 17:35:22 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIM...
Open
€87,00
High
€87,90
Low
€86,60
Mkt. cap
10,26 mjd
Avg. vol.
165,10 k
Volume
161,15 k
P/E ratio
22,26
52-wk high
€116,10
52-wk low
€65,60
EPS
€3,90
Shares outstanding
118,36 m
No. of employees
15 k
Open
€87,00
High
€87,90
Low
€86,60
Mkt. cap
10,26 mjd
Avg. vol.
165,10 k
Volume
161,15 k
P/E ratio
22,26
52-wk high
€116,10
52-wk low
€65,60
EPS
€3,90
Shares outstanding
118,36 m
No. of employees
15 k
News stories
From web sources and news partners
GlobeNewswire
·
51 minute gelede
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CNBC
·
41 minute gelede
The turnaround of this beaten-up Dow stock looks for real, says Katie Stockton
StreetInsider
·
20 minute gelede
Nuburu receives NYSE American warning over disclosure violations
Yahoo Finance
·
42 minute gelede
Linkage Global Regains Compliance with Nasdaq Minimum Bid Price Requirement
Profile
bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors.
bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock exchange. Wikipedia
About BioMerieux SA
CEOPierre Boulud
Employees14,9 k
Founded1963
HeadquartersMarcy-l'Étoile, Rhône-Alpes, Frankryk
SectorMedical device
Websitebiomerieux.com